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The use of cardiopulmonary exercise testing (CPET) to evaluate cardiac and respiratory function was pioneered as
part of preoperative assessment in the mid 1990s. Surgical procedures have changed since then. The patient
population may have aged; however, the physiology has remained the same. The use of an accurate physiological
evaluation remains as germane today as it was then. Certainly no ‘magic’ is involved. The author recognizes that
not everyone accepts the classical theories of the anaerobic threshold (AT) and that there is some discussion
around lactate and exercise. The article looks at aerobic capacity as an important predictor of perioperative
mortality and also looks at some aspects of CPET relative to surgical risk evaluation.Review
The ‘magic’ of it all!
The word ‘magic’ conjures up visions of Merlin, Camelot
and mystical beasts around 1100 AD. This was some
600 years before the real magic, that of Lavoisier, was
initiated. Antoine Laurent Lavoisier was beheaded in
1794 during the French Revolution but not before he
had measured oxygen uptake during exercise. This pro-
vided the fundamental foundation for modern CPET.
Lavoisier showed that during respiration oxygen is
consumed and carbon dioxide is given off. At the time
of Lavoisier’s work, chemistry was so underdeveloped
that it could hardly be called a science. At the beginning
of the eighteenth century, chemistry was alchemy; by the
end it was a science. For more detail on Lavoisier, the
reader is referred to references [1,2].
Far from being magic, the measurement of oxygen up-
take and the traditional exposition of the anaerobic
threshold (AT) is the result of a logical physiological pro-
gression [3]. It is the epitome of Vorsprung durch Technik.
This slogan, Progress through technology, has been used by
Audi AG since 1985. Although a cliché, it encapsulates
the author’s perception of cardiopulmonary exercise test-
ing. So many famous names have pursued the concepts
that underlie this physiology: Lavoisier, Krogh, Bohr,
Henderson, Dill, Wasserman, Whipp, Jones, to name a few.Correspondence: culham@westnet.com.au
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reproduction in any medium, provided the orA series of works published back-to-back in one jour-
nal in 1910 by August Krogh, a Nobel Laureate in 1920,
(‘The seven little devils’) [4] attracted special attention
because he demonstrated that ‘the absorption of oxygen
and elimination of carbon dioxide in the lungs take place
by diffusion and by diffusion alone. There is no trust-
worthy evidence of any regulation of this process on the
part of the organism’ [5]. This statement was in direct
conflict with the position of Christian Bohr, who be-
lieved there to be an active transport mechanism for the
transport of oxygen across the alveoli. (For a detailed
discussion on the disagreement between these two ti-
tans, see [6]). Krogh had also developed a cycle ergom-
eter with which he was able to measure insensible and
sensible fluid losses accurately during heavy exercise [5].
In 1914, Yandell Henderson named the oxygen pulse
as a most important quantitative measurement. It was
defined as ‘the oxygen extraction of one systolic dis-
charge’ [7]. Henderson went on in 1923 to state, ‘The
stroke volume of the heart is for physiological and clin-
ical purposes the most important quantitative function
of the whole body’ [8].
The Harvard Fatigue Laboratory, a laboratory of hu-
man physiology, was conceived in 1926 by LJ Henderson
and began operation in 1927. The staff of the Harvard
Fatigue Laboratory embraced a wide range of disciplines,
including physiology, biochemistry, psychology, biology,
medicine, sociology and anthropology. The research
performed by the laboratory reflected this diversity of
backgrounds; areas of research included the physicalis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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teractions, aging, and the stresses of high altitude and
climate. Equipment utilized by the staff in conducting
research included treadmills, a climatic room, an altitude
chamber and an animal room. The physiologist DB Dill
was the director of the laboratory from 1927 to 1946.
This laboratory was responsible for innumerable publi-
cations relating to exercise physiology [9].
In 1960, Julius Comroe, the Director of the Cardiovas-
cular Research Institute at the University of California in
San Francisco where Wasserman was working, pointed
out to him that heart disease in the USA was increasing
in epidemic proportions. Comroe asked Wasserman
how patients could be screened, noninvasively if pos-
sible, for early detection of heart failure and other heart
diseases (K Wasserman, personal communication). In
1963, Naimark, Wasserman and McIlroy showed that
exercise tests could usefully be employed to detect de-
grees of dysfunction in the cardiovascular system. The
onset of anaerobic metabolism, the AT, during exercise
could be detected in three ways; an increase in lactate
concentration in the blood, a decrease in arterial bicar-
bonate concentration and pH, and an increase in the re-
spiratory exchange ratio [10,11]. Wasserman showed
that the lactic acid must be buffered, by the volatile buf-
fer bicarbonate, producing an equal number of CO2
molecules to be added to the CO2 produced by aerobic
metabolism.
Since rapidly responding gas analyzers had recently
become available, Wasserman further suggested that the
CO2 produced by the bicarbonate buffering of lactic acid
might be measured breath-by-breath.
Comroe then suggested that Wasserman should pursue
these ideas (K Wasserman, personal communication). His
initial studies on the physiological underpinnings of this
work were with Naimark and McIlroy. They showed how
the respiratory exchange ratio could be measured on a
continuous basis during exercise studies. Further, they
showed that the increase in the respiratory exchange ratio
was related to work intensity [10].
Their first work on the AT was published in 1964 from
Stanford [11]. In 1967, Dr Wasserman was invited by
UCLA to become Division Chief at Harbor General
Hospital, later Harbor-UCLA Medical Center. Brian J
Whipp, then a predoctoral Fellow with Wasserman at
Stanford, moved with him: together they set up the exer-
cise physiology research laboratory and collaborated in
exercise physiology research.
With the development of digital computers later in the
1960s, WL Beaver, a physicist working at Central Re-
search at Varian Associates in Palo Alto, joined this in-
vestigation. This collaboration enabled the use of digital
computers for breath-by-breath exercise gas exchange
[12-14]; Vorsprung durch Technik?Wasserman, with colleagues such as Brian Whipp,
James Hansen, Daryl Sue, Kathy Sietsema, Dan Cooper,
Richard Casaburi and William Stringer, became the
driving force behind the development of cardiopulmonary
exercise testing in the clinical environment. To this day,
they still publish key literature on the information gained
about cardiac and respiratory function from cardiopulmo-
nary exercise testing. Many other names deserve mention
but the space available precludes that.
Enough has been said to deny the use of the term ‘magic
number’ to describe any part of the physiological evolu-
tion that describes cardiopulmonary exercise testing.
The anaerobic threshold (AT)
To turn to CPET, the term anaerobic threshold (AT)
embraces two quite separate issues. Is there a point that
defines ‘anaerobic’ and precisely what is meant by ‘anaer-
obic’? Is there a threshold? The reader is referred to a
masterly article by Whipp in 2008, ‘The anaerobic
threshold: yes, no, maybe!’ [15]. If in 2008 there was still
controversy over the term, then that alone warrants fur-
ther examination of just why.
The latest book by Wasserman et al. [16] could be
used with advantage to obtain a detailed description of
determination of the AT.
One issue that remains is the inter-rater and intra-rater
repeatability of the data measurements, in particular the
AT. This is impossible to quantify as it is related directly to
the experience of the physicians. In our laboratory it is un-
common, or rare, for there to be a significant disagreement.
Lactate
Anaerobic metabolism is not uniquely a feature of high
intensity work rates; on the contrary it is found at low
intensity work rates but does not represent a major
component of energy transfer under those conditions. It
is probable that there is a degree of anaerobic metabol-
ism at all work rates [17]. Certainly at the onset of exer-
cise there is an increase in ATP demand. This is met
from oxygen independent sources, such as phosphocrea-
tine hydrolysis and glycolysis [18]. This occurs in the
presence of normal tissue oxygenation but does not, in
the author’s opinion, constitute anaerobic metabolism in
the sense in which it is commonly used in clinical medi-
cine. Further lactate, the most commonly quoted suspect
as the end point of anaerobic metabolism, is falsely ac-
cused. Lactate is a product in the pathway of energy pro-
duction, not its endpoint. Lactate is produced by muscle
tissue at rest in the absence of any cause of hypoxia [19].
It was thought that lactate at the end of exercise was
converted back to glycogen in situ, thus requiring oxy-
gen, which was termed the ‘oxygen debt’. It is now rec-
ognized that lactate present at the end of exercise is
predominately oxidized [20]. To open this Pandora’s
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tate metabolism by Gladden [19] and by Stainsby [21].
The term ‘anaerobic threshold’ relates to a point during
increasing exercise where the increase in concentration
of lactate is accompanied by an almost equal reduction
in the concentration of bicarbonate. Put another way, it
is the highest work rate at which the concentration of
lactate does not show a consistent increase. The latter is
accompanied by an increase in CO2 output, a
phenomenon that was used by Beaver and colleagues to
estimate the AT by the almost universally used V-slope
[12]. Clinically, this point is most commonly identified
via a rapid incremental work-rate protocol on a cycle
ergometer but it can also be achieved on a treadmill.Some opposition and repudiation
In 2011, Hopker et al. [22] expressed concern over not
only the physiological mechanisms underpinning the
noninvasive determination of the AT but also the clinical
usage of the term. These authors suggested alternative
explanations for the relationship between the conven-
tionally estimated AT and surgical outcome. Whipp and
Ward strongly repudiate much of this article, strongly
supporting the conventional concepts of the AT [23].
The article by Hopker in turn quotes an article by
Péronnet, which addresses the buffering mechanisms op-
erating in exercise [24]. In their original article in 1964,
Wasserman and McIlroy [11] had pointed out that the
onset of anaerobic metabolism can be detected in three
ways: (1) as an increase in the lactate concentration in
arterial blood; (2) as a decrease in arterial blood bicar-
bonate concentration and pH; and (3) as an increase in
the respiratory exchange ratio.
In 2012 Wasserman reiterated that the AT is the V˙ O2
above which there is a sustained increase in arterial lactate
concentration and the ratio of lactate concentration to
pyruvate concentration during rapid incremental exercise
[25]. Because of the accompanying hydrogen ion increase
with lactate accumulation above the AT, and the buffer for
the accumulating lactic acid being bicarbonate, CO2 out-
put increases independently of O2 uptake above the AT. It
was argued by Beaver et al., therefore, that the AT can be
detected noninvasively at that point if there is no evidence
of hyperventilation relative to CO2, which would be
shown by an increase in the ventilatory equivalent for
CO2, indicating hyperventilation [26].
Péronnet acknowledges that while there are many
buffers in the muscle, bicarbonate is not the main buffer
in muscle and that the fall in bicarbonate concentration
does not mirror the rise in lactate concentration. The
facts are that there is a delay in the fall of HCO3
− con-
centration until after the lactate concentration rises;
after this the changes are very nearly equal and opposite[27]. Be this as it may, bicarbonate is the only buffer that
releases carbon dioxide into the blood. The fall in arter-
ial bicarbonate concentration that occurs pari passu
with this buffering is accompanied by an increase in ar-
terial lactate concentration that is very close to a mirror
change, in fact almost a millimole to millimole change
[21]. (Figure 1). Thus, at the time the arterial bicarbon-
ate level is falling there will be an increase in CO2 out-
put and a rise in arterial lactate level. If arterial blood
can be sampled at very short time intervals, it will be
seen that the rise in lactate level occurs a few seconds
before the change in bicarbonate level, [16] reflecting a
small contribution from non-CO2-yielding buffers [26].
Whatever other buffers are involved at this time they
will not affect this outcome. This point at which the ar-
terial lactate concentration increases indeed represents
the onset of lactate-related anaerobic metabolism. The
terms ‘lactic acidosis threshold’, ‘lactate threshold’ and
‘anaerobic threshold’ are all indicative of the same
physiological point but reflect differing modalities of
measurement. The moment in time that represents the
onset of anaerobic glycolysis can vary slightly, that is
reflecting the fact the rise in V˙ CO2 must occur after the
decrease in arterial HCO3
− concentration; the CO2 has to
reach the lungs in order to be removed! The temporal
differences in metabolism will mean that the AT is iden-
tified at slightly different points.
This is not to argue against the importance of other
buffering systems, but their function is important to the
regulation of H+ concentration rather than additional CO2
production. If we believe that CO2 is a result of buffering
of the lactate-associated proton by bicarbonate, then there
will no increase in CO2 over that generated by aerobic
metabolism, until ‘lactate acidosis’ becomes an issue.
There can be a very slight increase in arterial lactate con-
centration at low intensity exercise but no fall in bicarbon-
ate concentration or rise in V˙ CO2 [15]. When the
intensity of exercise increases, there will be a rapid forma-
tion of lactate at some point. The rapidity of this change
will depend on many factors but it typically will produce a
threshold-like increase in arterial lactate, which may take
the form of a rapid to very rapid change, that is, a thresh-
old, in the graph of lactate concentration against time.
The rapidity of the change will depend on the rate of
change of the work rate. It is important to remember that
lactate is itself a fuel for muscle metabolism both locally
during contraction and remotely in other muscle beds as
well as the heart. The liver, during exercise, is not a major
site of lactate clearance. Thus lactate is not reliant on one
method of removal from the blood stream [19]. There is
also a small amount of lactate as a pyruvate/lactate linked
moiety, and all of these processes may slow the rate of
change in arterial lactate [28]. Given that the source of this
change results from an increase in anaerobic metabolism,
Figure 1 Plot of base excess, lactate, V_ CO2 and V_ CO2. Simultaneous plot of lactate, base excess and gas exchange. This was obtained from a
man exercising on a cycle ergometer. Samples at one minute intervals. Note that the base excess falls very much as the reciprocal of the lactate
rise. Data from author’s laboratory.
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vindicates the use of the V-slope [14] method of determin-
ing the AT, which merely identifies this threshold point. It
is important that hyperventilation, producing a rise in
both ventilatory equivalents and a fall in end-tidal carbon
dioxide tension, is not mistaken for the AT.Risk assessment of surgical patients
What then represents a reasoned approach to risk as-
sessment of surgical patients using CPET? Aerobic cap-
acity, measured as peak V˙ O2 or AT, is reproducible and
an objective reflection of physical fitness.
The rapid incremental test evaluates cardiovascular
(CVS), respiratory and peripheral muscle issues. The re-
sults of the test are traditionally reported in conjunction
with the nine-panel plot advocated by Wasserman and
colleagues (Figure 2); the most current version can be
found in the fifth edition of Principles of Exercise Testing
and Interpretation (Figure 3) [16]. This is a means of
placing 15 variables onto 9 graphs and showing all the
relevant results on one piece of paper. I will use this
nine-panel format throughout this paper. The term
‘panel’ refers to this figure. This later plot uses ‘time’ on
the x-axis in the three left panels (Panels 2,6,9).
Why is the V-slope so important? Almost every com-
mercial metabolic cart, as a first option, estimates AT from
the relationship between CO2 output and oxygen uptake,
also termed the V-slope. (Figure 2, Panel 5) The com-
puters may allow the operator to determine the AT or
they may determine that point as part of the computer
program. It is rare for the arterial lactate or bicarbonate
levels to be actually measured. On its own, the V-slope is
not a sufficient criterion for AT determination. Furtherconfirmation of the AT should be sought from the ventila-
tory equivalent panel (Figure 2, Panel 6), and end-tidal gas
tensions (Figure 2, Panel 9) to rule out nonspecific
hyperventilation.Life after the AT
Many of the physiological responses to exercise undergo
significant change above the AT. These include an in-
crease in glycolysis resulting in increased lactate produc-
tion, metabolic acidosis and increase in the V˙ CO2, with
consequent increase in ventilation. These changes may
translate clinically to an actual improvement in exercise
competence, for example, an increase in O2 availability
due to a shift in the oxyhaemoglobin dissociation curve
[29] (the Bohr effect), allowing for greater tissue oxygen
extraction. An important but detrimental effect is that
exercise endurance is reduced. In simple terms, however,
once over the AT the athlete may no longer be able to
continue for an extended period as the build-up of lac-
tic-acid-derived proton load and fall in pH occurs. There
is a strong duration-intensity in this relationship in that
the higher the intensity the shorter the duration of exer-
tion. The fall in pH will inhibit muscle shortening vel-
ocity and inhibit the rate of glycolysis [30].Oxygen uptake: exercise vs. surgical stress
What has all this to do with the surgical stress response?
While most of these physiological changes are described
in relation to exercise many of the physiological changes
are seen in patients following postoperative stress. Global
oxygen uptake can increase by 50% following major sur-
gery [31].
Figure 2 Traditional nine-panel plot. This format emanates from Wasserman and colleagues. This is one of several formats currently used but
is by far the most common. There is a new format published recently from UCLA (Figure 3) and another one devised by Professor Whipp. The 9-
panel format allows 15 variables to be plotted on 9 graphs. Note in Panel 7, the lines indicating vital capacity, inspiratory capacity and maximum
ventilatory volume. This is useful in assessing respiratory function. Ve, minute volume, VO2 = oxygen uptake, HR = heart rate, VCO2 = carbon
dioxide output, Vt, tidal volume, RER = respiratory exchange ratio, PETO2 = partial pressure end-tidal oxygen, PETCO2 = partial pressure end-tidal
carbon dioxide. Data from author’s laboratory.
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global oxygen uptake in exercise compared to global
oxygen uptake in the postsurgical patient. Global oxy-
gen uptake does not reflect the maximal oxygen uptake
of a particular organ group; it is a weighted mean of all
oxygen-consuming sites. Looked at from another per-
spective, the ceiling for oxygen consumption aftersurgery is lower than the ceiling during exercise. To fur-
ther complicate the issue, postoperative V˙ O2 calculated
from cardiac output and arterial and mixed venous oxy-
gen content from pulmonary artery catheter data is nor-
mally indexed as ml.min−1.m2 whereas the metabolic
cart usually indexes V˙ O2 as ml.min
-1.kg-1. Note that this
does not take into account the height of the patient.
Figure 3 New nine-panel plot. This is the same test as Figure 2. The panel numbers refer to their original position in Figure 2. This new format
was first announced in [16]. Ve = minute volume, VO2 = oxygen uptake, HR = heart rate, VCO2 = carbon dioxide output, Vt = tidal volume, RER =
respiratory exchange ratio, PETO2 = partial pressure end-tidal oxygen, PETCO2 = partial pressure end-tidal carbon dioxide. Data from
author’s laboratory.
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in Figure 4.
Following surgery, the liver has a high oxygen demand
and the muscle, whilst mechanically at rest, becomes a
metabolic organ. Muscle is a site involved in the trans-
amination of the branch chain amino acids, valine, leu-
cine and isoleucine, and is thus able to convert glutamate
from Krebs cycle to glutamine. Pyruvate is converted to
alanine. Both glutamine and alanine, as well as lactate(C3H5O3
−), are transported to the liver where C3 carbon
skeletons are converted to glucose using free fatty acids
as the energy source. This is termed the Cori cycle (after
Carl Cori, Nobel Laureate in 1947). Lactate is produced
in higher quantities than might be thought, as much of
the postsurgical wound metabolism is lactate producing
[19,32,33]. The liver has, at best, a parlous blood supply,
as 75% of the blood supply is deoxygenated blood coming
via the hepatic portal system. Under conditions of
Figure 4 Relationship of AT measured as ml.min−1.kg−1 to AT ml.min−1.m2. The metabolic cart is usually programmed to index V_ O2 as ml.
min−1.kg-1 whereas the pulmonary artery catheter is programmed to index as ml.min-1.m2. Note that ml.min−1.m2 indirectly uses height in
indexing. Indexing as ml.min−1.kg−1 does not use height. This graph allows direct comparison. Data from author’s laboratory.
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as the blood supply becomes inadequate. In the liver there
is a segregation of function into zones of different metab-
olism. The periportal regions have differing functions
from the perivenous regions. The periportal regions are
gluconeogenic, whilst the perivenous are glycolytic [21].
This explains how the liver is capable of both net lactate
release and gluconeogenesis from lactate. It is important
that lactate can be metabolized at many other sites.
It follows that oxygen uptake response from an exer-
cise test is not directly comparable to that in a postoper-
ative patient. But in common with exercise, oxygen
uptake postoperatively in major surgery is high.
Preoperative cardiopulmonary status
In 1988 our group published the preoperative and post-
operative cardiovascular system (CVS) status of 100 pa-
tients scheduled for major surgery [31] as determined by
pulmonary artery catheter. The data in this paper agreed
with the work of Del Guercio [34] and showed that in
many instances the preoperative CVS status of many pa-
tients was poor yet frequently they had been passed as
clinically fit for surgery. Evaluation of preoperative pa-
tients via a pulmonary artery catheter has many limita-
tions, particularly in regard to pulmonary function. The
main pulmonary function evaluated is the apparent
intrapulmonary shunt at rest. The term CVS status is
best applied to such evaluation. On the other hand,
CPET evaluates cardiac, pulmonary and vascular func-
tion at rest and during exercise, thus justifying the term
‘cardiopulmonary’.In our initial study cardiac index was 2.2 l.min−1.m2 or
less in 11% of patients and a total of 20% had a cardiac
index of 2.4 l.min−1.m2 or less. Intrapulmonary shunt
equalled or exceeded 15% in 10% of patients. At that time,
we stated that from the then recent work by Szlachcic
[35], ‘it would appear that exercise V˙ O2 may well detect
patients who are unlikely to survive for 12 months be-
cause of their existing cardiovascular disease. To perform
major surgery on this subset of patients is highly likely to
lead to death early in the postoperative period.’ We felt
that such methods of evaluation warranted more study in
the surgical population. This then was the stimulus that
made us investigate the cardiopulmonary status of pre-
operative patients by integrated CPET.The advantage of CPET evaluation of surgical patients
From the data that we had accumulated over many years
it seemed that cardiac failure was the major cause of
postoperative complications, not myocardial ischaemia.
CPET could noninvasively measure and grade cardiac
failure as well as detect myocardial ischaemia, both
from the actual test as well as the electrocardiogram
(ECG) [36]. For this reason, we felt that CPET was
much more informative than an ECG stress test in as-
sessment of operative risk analysis. More recently CPET
has been demonstrated to predict all-cause postopera-
tive mortality [37], to predict early mortality from
cardiac failure in patients scheduled for heart trans-
plantation [38] and to predict five-year survival after
major surgery [39].
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which we analyzed 548 elderly patients who underwent
CPET prior to major surgery [40]. All patients with an
AT of <11 ml.min−1.kg−1 were admitted to the intensive
care unit (ICU) preoperatively and monitored with a
pulmonary artery catheter.
The papers of Weber, Janicki and colleagues [41,42]
graded cardiac failure on the basis of both AT and peak
V˙ O2 (Figure 5). We chose to use the AT, as in our ex-
perience meaningful peak V˙ O2 values are hard to obtain
with consistency in the elderly. Our study results may
differ from a hospital study performed today. Differences
may include the level of care of postoperative patients
on the wards, protocols of management within the ICU
and experience in performing and interpretation of the
exercise test.
CPET is not a therapeutic tool; it merely suggests the
appropriate area of management based on operative risk.
All patients with an AT lower than 11 ml.min−1.kg−1
were admitted by us to the ICU preoperatively and man-
aged using pulmonary artery data. The same manage-
ment applied to any patient defined as being in an area
of ‘surgery-specific risk’ [43]. This policy resulted in 25%
of all elderly patients having major surgery being admit-
ted to ICU. If we were to perform this study today we
also might find some different results, as postsurgical
care should have improved over the intervening 12 to 13
years. Some critics of our paper have argued that the
extra care lavished on the high-risk patients was a piv-
otal reason that they had such a low mortality. They
may be right but if a little more care translates into a
better mortality rate, the message is clear!
A further issue that became very important was that
we were able to show that age was not a discriminator
of mortality. This was highlighted by Wasserman in
1993 [44]. This needs to be borne in mind, as almost all
‘clinical’ discriminators of mortality rank ‘age’ as a key
indicator of perioperative risk [45].Which variables are predictive?
To use AT values of exactly 11 ml.min−1.kg−1 as an indi-
cator that the patient is fit to be managed on the ward,Figure 5 Triage according to AT. Patients with either no cardiac
failure or mild to moderate cardiac failure are triaged to the ward.
Only patients with moderate to severe or severe cardiac failure are
triaged to ICU. Data modified from [42].is to place too much emphasis on just one factor. Note
that using the Weber and Janicki classification an AT
greater than 11 ml.min−1.kg−1 but under 14 ml.min−1.kg−1
still indicates mild cardiac failure [31].
In our 1999 paper [40], we used both the ATand the ven-
tilatory equivalent for oxygen V˙ e=V˙ O2
 Þ as part of the
predictive process. We also used the oxygen uptake to work
rate ratio (the V˙ O2 /WR slope) and the oxygen pulse but
did not place predictive numbers on these variables.
I think I must take the blame for such a ‘black and
white’ approach to the numbers and would urge the
greater use of ‘shades of grey’. There is a thread of misun-
derstanding linking some of the large number of tests
emailed to me for comment. Cardiac failure does not ex-
hibit a stepwise deterioration over time. The deterioration
is more a linear issue, thus an AT of 10.9 ml.min−1.kg−1 is
not very different from an AT of 11.1 ml.min−1.kg−1; in
fact the inter- and intra-rater variability might argue that
they are the same. One manufacturer has developed a
graphical display to show the AT and V˙ O2 /WR lying on a
coloured line that gradually changes from red to green via
yellow (Figure 6). This may well be improved if the col-
ours change from red to yellow through orange and from
yellow to green through lime green.
Some studies do not find the AT as useful as the peak
V˙ O2 [46-48]. This causes me no concern, as the peak
V˙ O2 is also a measure of aerobic capacity. The issue
here is that the authors of these studies agree with our
group, that aerobic capacity is the main factor correlat-
ing with survival rather than myocardial ischaemia. The
largest study available confirming that heart failure is a
greater surgical risk than myocardial ischaemia is that
published by Hernandez et al. in 2004 [49].
I do have concern over the term ‘V˙ O2max ’, as it is often
taken as synonymous for peak V˙ O2 . The definition of
V˙ O2max is the highest V˙ O2 attainable by the subject des-
pite increases in workload; anything less is the peak V˙ O2
[50,51].Where are we today?
The AT
Certainly a lot of attention needs to be paid to the
AT (Figure 2, Panels 5, 6 and 9) but also to the ventila-
tory equivalents (Figure 2, Panel 6), the oxygen pulse
(Figure 2, Panel 2), the V˙ O2/WR slope (Figure 2, Panel 3)
and ventilatory efficiency (Figure 2, Panel 4). The AT still
measures surgical risk and even though the numbers
may have changed over the years I would still stay with
the numbers that we published in 1999 [40], at least
until some more recent numbers are published. We
could perhaps measure the AT and use a little more lati-
tude in its interpretation. Perhaps an equation could be
Figure 6 Colour graphics interpretation of AT and V_ O2 /WR slope. This graphic shows the gradual change from high risk (red) to low risk
(green) via an area of caution (yellow). It plots the AT and the V_ VO2 /WR slope. This minimizes the assumption that an AT of 10.9 ml.min
−1.kg−1
is very different from an AT of 11.1 ml.min−1.kg−1 (see text). Reproduced with permission from Cortex Biophysik GmbH.
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give a better risk analysis.
Generally, if the AT is less than 11 ml.min−1.kg−1,
other parameters may well be abnormal. If, however, the
AT were to be a little low, the surgery less stressful, for
example a right hemicolectomy rather than a left, but the
other parameters normal, the patient could go to the ward.
This is not the place for a discussion of ‘Outreach’ but this
is the sort of patient that could benefit from the attention
of the ‘Outreach’ team [52]. The converse is easily managed.
If the AT is a little greater than 11 ml.min−1.kg−1 but other
parameters are abnormal, the patient should definitely go
to the ICU. This is what I mean by ‘shades of grey’. It is
safer to discharge someone from the ICU early than to
admit someone to the ICU late!
If ventricular function is good then the increase in
V˙ O2 during exercise should be 10 ml.min
−1.watt−1 or
certainly better than 8 ml.min−1.watt−1, as most of
our patients are sedentary (Figure 2, Panel 3). In
some very fit patients the slope is over 11 ml.min−1.
watt−1. This can cause some confusion. If the figure
is 11 ml.min−1.watt−1 then might this imply a reduc-
tion in ‘efficiency’ as the subject is using more oxygen
to achieve each watt than an elderly patient who has
a slope of 8 ml.min−1.watt−1? The answer is elusive
but it may result from utilization of different oxida-
tive muscle fibres, utilization of additional muscle
groups at high work rates or even an increase in the
work of breathing at high minute volum. It does not
imply anything sinister.The oxygen pulse
The oxygen pulse should be near normal and the shape
should be appropriate, that is, not an early low plateau.
The ‘normal’ peak value of the oxygen pulse is the max-
imum predicted V˙ O2 in millilitres, divided by the max-
imum predicted heart rate. Obviously, the use of
different predictive nomograms will alter predictive
values for other parameters including the oxygen pulse.
If the peak V˙ O2 is low but acceptable for the age of the
patient then the oxygen pulse will also be reduced. The
profile is as important as the actual value.The oxygen pulse is also influenced by the haemoglo-
bin via the C(a – v)O2:
Oxygenpulse ¼ VO2=HR ¼ C a–vð ÞO2  CO=HR
¼ C a–vð ÞO2xSV;
where C(a − v)O2 is arteriovenous oxygen difference, CO
is cardiac output and SV is stroke volume.
The C(a − v)O2, the arteriovenous oxygen content dif-
ference, is influenced by the haemoglobin levels, such
that a fall in haemoglobin concentration will result in a
reduction in the C(a − v)O2 and thus a fall in oxygen
pulse. To maintain the V˙ O2, the stroke volume will need
to be elevated.
It is possible to estimate the stroke volume at AT from
the equation:
SV ¼ O2pulse=C a–vð ÞO2
  normalHb=actualHb
SV ¼ 9=0:1 150=120 ¼ 9 10 150=120
SV≈120ml:
Assuming that C(a − v)O2 is 10ml/100 ml blood, Hb is
120 grams/litre, oxygen pulse is 9 and putative normal
for haemoglobin is 150ml/litre
The C(a − v)O2 is (conveniently) approximately 10 ml per
100 ml of blood at the AT over a wide range of patients
[53]. This measurement is difficult to make as it is very
hard to be certain that the patient is at the AT when the
arterial and mixed venous blood samples are taken.
The oxygen pulse may cause some confusion when
the patient is taking beta-adrenergic blocking drugs. It
has been shown that the resting heart rate may not be
indicative of the extent of beta-blockade [54]. The
exercise heart rate is a far better guide. Bear in mind
that the extent of the chronotropic response to beta-
blockade is not necessarily the same as the extent of
the inotropic response. If the heart rate is attenuated,
the only way in which cardiac output can be increased
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the oxygen pulse over normal (Figure 7b). If this does
not occur (Figure 7a), the cardiac output will be
compromised and this will limit both the AT and the
essential postsurgical response. It is the author’s view
that this situation is an absolute indication of a need to
review the beta-adrenergic blocking drugs if the patient
is scheduled for major surgery. For a detailed discussion
of beta-blocking agents and surgery see the POISE
study [55].The ventilatory equivalents
The ventilatory equivalents (Figure 2, Panel 6) are more
of a problem. We have always viewed the ventilatory
equivalent for CO2 (V˙e / V˙ CO2 ) as more of an indica-
tion of ventilatory function and have used the ventilatory
equivalent for O2 (V˙e / V˙ O2) as more related to the AT.
Figure 8 shows the relationship of V˙e / V˙ O2. VO2 to AT
of over 1,000 patients from the author’s laboratory.
There is clearly a rise in V˙e / V˙ O2 as the AT falls.
We feel that a value for the V˙e / V˙ O2 that is signifi-
cantly outside this range, even if the AT is above 11
ml.min−1.kg−1, is an indicator that should guarantee
high-dependency unit (HDU) admission. Providing
that the V˙e / V˙CO2 does not rise and the end-tidal
oxygen tension does not fall, the nadir of the V˙e / V˙ O2
slope corresponds to the AT. If the AT cannot be
identified by the V-slope method, then the nadir of
the V˙e / V˙ O2 slope (Figure 2, Panel 6) is often quite
usable as an alternative. We found that there was al-
most an 80% correlation between the AT derived by
V-slope and V˙e / V˙ O2 nadir.Figure 7 Oxygen pulse under two different conditions. (a,b) Panel 2 o
patients are taking beta-adrenergic blocking drugs. (a) A low oxygen pulse
the low pulse rate and the compensating elevated oxygen pulse. The loweThere is good evidence that the ventilatory efficiency re-
flects 'respiratory function and is shown by a V˙e / V˙ CO2
slope of between 20 and 30 (over the linear region of the
V˙e / V˙ CO2 relationship, which normally extends upo the
respiratory compensation point). This slope is usually very
similar to the lowest V˙e / V˙ CO2 ratio (Figure 2, Panel 6).
The lowest V˙e / V˙ CO2 value has been shown to be prefera-
ble as a noninvasive marker to the V˙e / V˙ CO2 slope for the
AT [56]. Abnormal ventilatory efficiency is associated with
respiratory difficulties postoperatively and may become an
indication for ICU management in the early postoperative
period. It is preferable to admit such patients to ICU whilst
still ventilated and extubate when everything else is final-
ized, for example, pain control.
As all our patients with a low AT were admitted to the
ICU preoperatively and monitored by pulmonary artery
catheters, we had an opportunity to investigate the rela-
tionship of the V˙e / V˙ O2 to the pulmonary artery pres-
sures and pulmonary vascular resistance index (PVRI).
The results were not quite as we expected. We studied
224 consecutive patients of whom 57 had an AT <10 ml.
min−1.kg−1. Of these, 25 went to the ICU and on to sur-
gery and thus we had access to pulmonary vascular data
in this group of patients. We were able to compare these
patients with those who did not have elevation of the
ventilatory equivalents. We viewed all values for PVRI of
over 35 kPa.L-1.s (350 dynes.s.cm-5)as of significance for
postoperative care. We did not rely on the values for
pulmonary artery pressures. Some patients following
major surgery exhibit a fall in PVRI and others do not.
We were unable to predict this response. We found that
the V˙e / V˙ O2 needed to be over 45 to be certain that the
patient has a PVRI > 35 kPa.L-1.s (Figure 9) It wasn the traditional Wasserman et al. 9-panel plot. In both cases, the
in a woman. (b) An elevated oxygen pulse on a female patient. Note
r horizontal dotted line is the predicted value.
Figure 8 AT ml.min−1.kg−1 vs. V_e / V_ O2. This graph shows how the V˙e / V_O2 rises as the value of the AT falls. A value for V˙e / V_O2 of greater
than 35 is abnormal. Data from the author’s laboratory.
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˙ O2 of 35 who
had a PVRI of over 350 dynes.s.cm−5.
Any patient with a Ve/ V
˙ O2 of 45 or greater should
be investigated with a pulmonary artery catheter to es-
tablish the actual PVRI and cardiac output and then
managed in the ICU.Conclusions
This paper may appear to have stopped in full flight.
Maybe it has, because we certainly have not learnt howFigure 9 Pulmonary vascular resistance vs. V_ e / V_ O2. All patients in th
large variation in pulmonary vascular resistance with a V˙e / V_O2 of greater
exceed 35 kPa.L-1.s, the Ve / V
_O2 needs to be greater than 45. Note the PV
author’s laboratory.to garner all that we can from CPET. Calls have been
made to develop a more ‘robust’ test than this for peri-
operative use [57]. I feel that what is needed is a greater
‘in-depth’ analysis of what we already have. CPET is not
a ‘magic number’ and has basis in sound physiological
principles.
Which patients should we test? If you think that only
those with heart disease need testing, then there is no
point in testing anybody! You already have a diagnosis in
those who have heart disease and you will miss the rest,
as they won’t be tested. Everybody over the age of 60is study had an AT of 10 ml.min−1.kg−1 or less. The graph shows the
than 35. To be certain that the pulmonary vascular resistance will
RI of those patients with a V˙e / V_O2 of 35. Data from the
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not a surrogate for physical fitness, as many people who
regard themselves as ‘fit’ turn out on CPET to have sig-
nificant but subclinical cardiac failure.
If you wish to be more precise, look at your hospital
morbidity and mortality data and see the age at which
‘problems’ seem to be occurring.
Finally, it is mainly anaesthetists who will be carrying
out these tests; they have a very different perspective of
heart failure from cardiologists and you may well need
their advice in certain areas. CPET is not intended to re-
place clinical examination or clinical judgement; it is
designed to supplement them.
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